ID   CBIGi001-A-1
AC   CVCL_C0JZ
SY   PRKN-KO; AIW002-02/PRKN-KO; PRKN-KO/AIW002-02; Parkin-KO/AIW002-02
DR   BioSamples; SAMEA12565661
DR   hPSCreg; CBIGi001-A-1
DR   Wikidata; Q112929367
RX   PubMed=35561458;
WW   https://cbigr-open.loris.ca/c-big_ipsc_catalog_May2022.pdf
CC   From: Clinical Biospecimen Imaging and Genetic (C-BIG) Repository, Montreal Neurological Institute, McGill University; Montreal; Canada.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; 8607; PRKN.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_C0JY ! CBIGi001-A
SX   Male
AG   37Y
CA   Induced pluripotent stem cell
DT   Created: 23-06-22; Last updated: 29-06-23; Version: 4
//
RX   PubMed=35561458; DOI=10.1016/j.scr.2022.102806;
RA   Chen C.X.-Q., You Z.-P., Abdian N., Sirois J., Shlaifer I., Tabatabaei M.,
RA   Boivin M.-N., Gaborieau L., Karamchandani J., Beitel L.K., Fon E.A.,
RA   Durcan T.M.;
RT   "Generation of homozygous PRKN, PINK1 and double PINK1/PRKN knockout
RT   cell lines from healthy induced pluripotent stem cells using
RT   CRISPR/Cas9 editing.";
RL   Stem Cell Res. 62:102806-102806(2022).
//